Related Experiment Video
Updated: Jun 29, 2026

11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.4K
Risk assessment for o-toluidine and bladder cancer incidence.
Robert M Park1, Tania Carreón2,3, Kevin W Hanley3
1Division of Science Integration, National Institute for Occupational Safety and Health, Cincinnati, Ohio, USA.
American Journal of Industrial Medicine
|June 11, 2021
Summary
Workers exposed to o-toluidine (OT) in the rubber industry face an elevated bladder cancer risk. Even low OT exposure levels (1 ppb) may increase lifetime cancer risk, highlighting the need for stricter occupational safety standards.
Area of Science:
- Occupational Health
- Toxicology
- Epidemiology
Background:
- Elevated bladder cancer incidence observed in rubber industry chemical workers (1946-2006).
- o-Toluidine (OT), an aromatic amine, identified as a prime suspect agent.
- Aniline, also present, is an animal carcinogen but showed lower worker exposure markers than OT.
Purpose of the Study:
- To conduct a quantitative risk assessment for bladder cancer in rubber industry workers.
- To estimate cumulative o-toluidine (OT) exposures.
- To evaluate bladder cancer incidence models considering healthy worker survivor effects.
Main Methods:
- Quantitative risk assessment using historical environmental data and worker exposure records.
- Estimation of cumulative OT exposures based on exposure intensity ranks and direct environmental sampling.
- Analysis of bladder cancer incidence with adjustments for workforce turnover and survivor bias.
Main Results:
- Estimated excess lifetime risk of bladder cancer from OT exposure at 1 ppb ranged from 1 to 7 per thousand.
- Risk estimates were derived under various workforce turnover assumptions.
Conclusions:
- Current occupational exposure limits for OT (ACGIH TLV, OSHA standards) are significantly higher (1000-fold) than levels associated with a 1-7 per thousand excess lifetime risk.
- The findings suggest that existing occupational safety standards for o-toluidine may not adequately protect workers from bladder cancer.

